Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05281263 |
|
Recruitment Status :
Active, not recruiting
First Posted : March 16, 2022
Last Update Posted : February 21, 2023
|
Sponsor:
Blue Lake Biotechnology Inc.
Information provided by (Responsible Party):
Blue Lake Biotechnology Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2, 2023 |
| Estimated Study Completion Date : | June 2, 2023 |